
Girinimbine
CAS No. 23095-44-5
Girinimbine( —— )
Catalog No. M37784 CAS No. 23095-44-5
Girinimbine (Girinimbin) is a carbazole alkaloid isolated from the plants M. koenigii, M. koenigii, and Murraya koenigii.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 628 | Get Quote |
![]() ![]() |
5MG | 930 | Get Quote |
![]() ![]() |
10MG | 1254 | Get Quote |
![]() ![]() |
25MG | 1803 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGirinimbine
-
NoteResearch use only, not for human use.
-
Brief DescriptionGirinimbine (Girinimbin) is a carbazole alkaloid isolated from the plants M. koenigii, M. koenigii, and Murraya koenigii.
-
DescriptionGirinimbine (Girinimbin) is a carbazole alkaloid with a variety of biological effects. Girinimbine can induce apoptosis, and has antitrypanosomal, antiplatelet activity, antibacterial activity, anti-inflammatory, antioxidant and antitumor activities.
-
In VitroGirinimbine (1-400 μM; 24-72 h) decreases the viability of HepG2 cells in 24, 48 and 72 h with IC50 values of 61 μM, 56 μM, and 40 μM respectively. Girinimbine (10-100 μM; 24-48 h) increase of LDH leakage in both concentration- and time-dependent manner in HepG2 cells.Girinimbine (56 μM; 24-48 h) treatment results in DNA fragmentation and elevates levels of caspase-3 in HepG2 cells.HepG2 cells.Girinimbine (56 μM; 12-48 h) treatment also displays a time-dependent accumulation of the Sub-G0/G1 peak (hypodiploid) and caused G0/G1-phase arrest.Girinimbine shows a potent antitrypanosomal activitywith an IC50 value of 10.16 μg/mL.Cell Viability Assay Cell Line:HepG2 cells Concentration:1 μM, 10 μM, 50 μM, 100 μM, 200 μM Incubation Time:24 h, 48 h and 72 h Result:Inhibited the proliferation of HepG2 cells in vitro in a dose- and time-dependent manner.Apoptosis Analysis Cell Line:HepG2 cells Concentration:56 μM Incubation Time:24 h, 48 h Result:Showed typical morphological features of apoptosis.Cell Cycle Analysis Cell Line:HepG2 cells Concentration:56 μM Incubation Time:12 h, 24 h, 48 h Result:Induced G0/G1-phase arrest in HepG2 cells.
-
In VivoGirinimbine (10-100 mg/kg; orally gavage; once) pretreatment helps limit total leukocyte migration, and reduced pro-inflammatory cytokine (IL-1β, TNF-α) levels in the peritoneal fluid. In vivo in zebrafish embryos, Girinimbine (20 μg/mL; 24 hours) shows significant distribution of apoptotic cells in embryos.Animal Model:Male ICR mice (25-35 g) treated with carrageenan Dosage:10 mg/kg, 30 mg/kg, and 100 mg/kg Administration: Orally gavage; once Result:Helped limit total leukocyte migration, and reduced pro-inflammatory cytokine levels in the peritoneal fluid.
-
Synonyms——
-
PathwayOthers
-
TargetAntioxidant
-
RecptorAntioxidant | Apoptosis | Antibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number23095-44-5
-
Formula Weight263.33
-
Molecular FormulaC18H17NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1cc2c3ccccc3[nH]c2c2C=CC(C)(C)Oc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Suvitha Syam, et al. The growth suppressing effects of girinimbine on HepG2 involve induction of apoptosis and cell cycle arrest. Molecules. 2011 Aug 23;16(8):7155-70.?
molnova catalog



related products
-
Kadsurin
Kadsurin has anti-oxidant activity, it induces enzymes capable of scavenging oxygen radical species in the liver.
-
BMY 7378 dihydrochlo...
BMY-7378, α1D-adrenergic receptor antagonist, is a weak partial agonist/antagonist of 5-HT1A receptor.
-
KukoaMine B
Kukoamine B is a component of Lycii Cortex with anti-oxidant anti-acute inflammatory and anti-diabetic properties.